IL37 and breast carcinoma: However, various IL-23-overexpressing murine cancer cells, such as colon cancer, melanoma, fibrosarcoma, mammary carcinoma, glioma and hepatocellular carcinoma, impaired tumor growth in vivo compared with wild type tumor cells 33.